/s/ Davidson & Company LLP | ||
Vancouver, Canada |
Chartered Professional Accountants |
/s/ Davidson & Company LLP | ||
Vancouver, Canada |
Chartered Professional Accountants |
Note |
December 31, 2022 |
December 31, 2021 |
||||||||||
Assets |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
$ |
$ |
||||||||||
Receivables and prepaid expenses |
||||||||||||
Prepaid licence fees |
||||||||||||
Deposits |
||||||||||||
Non-current assets |
||||||||||||
Property and equipment |
5 | |||||||||||
Oyu Tolgoi assets |
6 | |||||||||||
Total assets |
$ |
$ |
||||||||||
Liabilities |
||||||||||||
Current liabilities |
||||||||||||
Accounts payable and accrued liabilities |
17 | $ |
$ |
|||||||||
Current portion of lease liabilities |
7 | |||||||||||
Non-current liabilities |
||||||||||||
Lease liabilities |
7 | |||||||||||
Loan payable to Oyu Tolgoi LLC |
8 | |||||||||||
Deferred revenue |
9 | |||||||||||
Total liabilities |
||||||||||||
Shareholders’ deficiency |
||||||||||||
Share capital |
10 | |||||||||||
Reserves |
||||||||||||
Accumulated other comprehensive income (loss) |
( |
|||||||||||
Deficit |
( |
( |
||||||||||
Total shareholders’ deficiency |
( |
( |
||||||||||
Total liabilities and shareholders’ deficiency |
$ |
$ |
Note |
2022 |
2021 |
2020 |
|||||||||||||
Expenses |
||||||||||||||||
Project expenditures |
12 | $ |
$ | $ | ||||||||||||
General and administrative |
10 | |||||||||||||||
Share-based compensation |
10,17 | |||||||||||||||
Depreciation |
5 | |||||||||||||||
Operating loss |
||||||||||||||||
Foreign exchange loss (gain) |
( |
( |
||||||||||||||
Interest income |
( |
( |
( |
|||||||||||||
Interest expense |
8 | |||||||||||||||
Loss from equity investee |
6 | |||||||||||||||
Finance costs |
||||||||||||||||
Deferred revenue finance costs |
9 | |||||||||||||||
Loss for the year |
||||||||||||||||
Other comprehensive (gain) loss |
||||||||||||||||
Foreign currency translation |
( |
|||||||||||||||
Total comprehensive loss |
$ |
$ | $ | |||||||||||||
Net loss per common share |
||||||||||||||||
Basic and fully diluted |
$ |
( |
$ | ( |
$ | ( |
||||||||||
Weighted average number of common shares outstanding |
||||||||||||||||
Basic and fully diluted (000’s) |
||||||||||||||||
Total common shares issued and outstanding (000’s) |
10 |
Note |
Number of Shares (000’s) |
Share capital |
Reserves |
Accumulated other comprehensive income (loss) |
Deficit |
Total |
||||||||||||||||||||
Balance at December 31, 2021 |
$ | |
$ | $ | ( |
$ | ( |
$ | ( |
|||||||||||||||||
Loss and comprehensive income |
- |
- |
- |
( |
( |
|||||||||||||||||||||
Share-based compensation |
10 | - |
- |
- |
- |
|||||||||||||||||||||
Issuance of share capital – share options |
10 | ( |
- |
- |
||||||||||||||||||||||
Issuance of share capital – deferred share units |
10 | ( |
- |
- |
- |
|||||||||||||||||||||
Issuance of share capital – warrants |
10 | ( |
- |
- |
||||||||||||||||||||||
Balance at December 31, 2022 |
$ |
$ |
$ |
$ |
( |
$ |
( |
|||||||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | ( |
$ | ( |
$ | ( |
||||||||||||||||||
Loss and comprehensive loss |
- |
- |
- |
( |
( |
( |
||||||||||||||||||||
Share-based compensation |
- |
- |
- |
- |
||||||||||||||||||||||
Issuance of share capital – share options |
( |
- |
- |
|||||||||||||||||||||||
Issuance of share capital – warrants |
( |
- |
- |
|||||||||||||||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
( |
$ |
( |
$ |
( |
||||||||||||||||||
Balance at December 31, 2019 |
$ | $ | $ | ( |
$ | ( |
$ | ( |
||||||||||||||||||
Loss and comprehensive loss |
- | - | - | ( |
( |
( |
||||||||||||||||||||
Share-based compensation |
- | - | - | - | ||||||||||||||||||||||
Issuance of share capital – private placement |
- | - | ||||||||||||||||||||||||
Issuance of share capital – share options |
( |
- | - | |||||||||||||||||||||||
Share issuance costs |
- | ( |
- | - | - | ( |
||||||||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | ( |
$ | ( |
$ | ( |
Note |
2022 |
2021 |
2020 |
|||||||||||
Cash flows used in operating activities |
||||||||||||||
Net loss |
$ |
( |
) |
$ | ( |
) | $ | ( |
) | |||||
Items not affecting cash: |
||||||||||||||
Depreciation |
5 | |||||||||||||
Share-based compensation |
10 | |||||||||||||
Loss from equity investee |
6 | |||||||||||||
Interest expense |
8 | |||||||||||||
Finance cost, net |
||||||||||||||
Unrealized foreign exchange loss (gains) |
( |
) | ( |
) | ||||||||||
Deferred revenue finance costs |
9 | |||||||||||||
Other |
- | |||||||||||||
( |
) |
( |
) | ( |
) | |||||||||
Changes in non-cash operating working capital: |
||||||||||||||
Increase in receivables and prepaids |
( |
) |
( |
) | ( |
) | ||||||||
Increase (decrease) in accounts payable and accrued liabilities |
( |
) | ||||||||||||
( |
) |
( |
) | ( |
) | |||||||||
Cash flows used in investing activities |
||||||||||||||
Purchase of equipment |
5 | - |
( |
) | - | |||||||||
( |
) | - | ||||||||||||
Cash flows from financing activities |
||||||||||||||
Repayment of lease liability |
7 | ( |
) |
( |
) | ( |
) | |||||||
Proceeds from issuance of common shares – share options |
10 | |||||||||||||
Proceeds from issuance of common shares – warrants |
10 | - | ||||||||||||
Proceeds from issuance of common shares – private placement |
10 | - |
||||||||||||
Share issuance costs |
- |
( |
) | |||||||||||
(Decrease) increase in cash and cash equivalents |
( |
) |
( |
) | ||||||||||
Cash and cash equivalents - beginning of year |
||||||||||||||
Effect of exchange rate changes on cash and cash equivalents |
( |
) |
||||||||||||
Cash and cash equivalents - end of year |
$ |
$ | $ | |||||||||||
Cash and cash equivalents is represented by: |
||||||||||||||
Cash |
$ |
$ | $ | |||||||||||
Cash equivalents |
||||||||||||||
Total cash and cash equivalents |
$ |
$ | $ |
1 |
Nature of operations |
2 |
Basis of presentation |
3 |
Use of estimates and judgements |
a) |
Determination of functional currencies |
b) |
Income taxes |
c) |
Share-based compensation |
d) |
COVID-19 |
4 |
Significant accounting policies |
a) |
Basis of consolidation |
b) |
Foreign currency translation |
c) |
Financial instruments |
Financial assets / liabilities |
Classification |
|||||
Cash and cash equivalents |
Amortized cost | |||||
Receivables |
Amortized cost | |||||
Deposits |
Amortized cost | |||||
Accounts payable and accrued liabilities |
Amortized cost | |||||
Lease liabilities |
Amortized cost | |||||
Loan payable to Oyu Tolgoi LLC |
Amortized cost |
d) |
Cash and cash equivalents |
e) |
Exploration and evaluation assets |
All direct costs related to the acquisition of mineral property interest are capitalized in the period incurred. Exploration and evaluation costs are charged to profit or loss in the period incurred until such time as it has been determined that a mineral property has proven and probable reserves and the property is economically viable, in which case subsequent evaluation costs incurred to develop a mineral property are considered for capitalization. |
f) |
Property, plant and equipment |
g) |
Long-term investments |
h) |
Decommissioning obligations |
i) |
Other provisions |
j) |
Taxation |
k) |
Share-based compensation |
l) |
Deferred share units |
m) |
Loss per share |
n) |
Related party transactions |
o) | Right-of-use |
• | fixed payments, including in-substance fixed payments, less any lease incentives receivable; |
• | variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date; |
• | amounts expected to be payable under a residual value guarantee; |
• | exercise prices of purchase options if the Company is reasonably certain to exercise that option; and |
• | payments of penalties for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease. |
p) |
Warrants issued in equity financing transactions |
q) |
Standards issued or amended but not yet effective |
5 |
Property and equipment |
Office equipment |
Computer equipment |
Buildings |
Right-of-use assets |
Total | ||||||||||||||||
Cost |
||||||||||||||||||||
Balance, January 1, 2020 |
$ | $ | $ | $ | $ | |||||||||||||||
Foreign exchange |
||||||||||||||||||||
Balance, December 31, 2020 |
||||||||||||||||||||
Additions |
- | - | ||||||||||||||||||
Disposals |
( |
) | ( |
) | - | - | ( |
) | ||||||||||||
Foreign exchange |
||||||||||||||||||||
Balance at December 31, 2021 |
||||||||||||||||||||
Additions |
- |
- |
||||||||||||||||||
Foreign exchange |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||
Balance at December 31, 2022 |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
Accumulated depreciation |
||||||||||||||||||||
Balance, January 1, 2020 |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||||
Depreciation |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
Foreign exchange |
( |
) | ( |
) | ( |
) | ||||||||||||||
Balance, December 31, 2020 |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
Disposals |
- | - | ||||||||||||||||||
Depreciation |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
Foreign exchange |
( |
) | ||||||||||||||||||
Balance at December 31, 2021 |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||
Depreciation |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||
Foreign exchange |
||||||||||||||||||||
Balance at December 31, 2022 |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||
Net book value |
||||||||||||||||||||
January 1, 2021 |
$ | $ | $ | $ | $ | |||||||||||||||
December 31, 2021 |
$ | $ | $ | $ | $ | |||||||||||||||
December 31, 2022 |
$ |
$ |
$ |
$ |
$ |
6 |
Oyu Tolgoi assets |
7 |
Leases |
December 31, 2022 |
December 31, 2021 | |||
Lease liability |
$ |
$ | ||
Less: current portion |
( |
( | ||
Long-term portion |
$ |
$ |
December 31, 2022 |
December 31, 2021 | |||
Less than one year |
$ |
$ | ||
One to five years |
- | |||
$ |
$ |
8 |
Loan payable to Oyu Tolgoi LLC |
9 |
Deferred revenue |
• |
• |
10 |
Share capital |
a) | Common shares |
b) | Net loss per common share |
c) | Private placement |
d) | Share options |
Number of share options (000’s) |
Weighted average exercise price C$ |
|||||||
Outstanding – December 31, 2019 |
||||||||
Granted |
||||||||
Exercised |
( |
|||||||
Cancelled |
( |
|||||||
Forfeited/expired |
( |
|||||||
Outstanding – December 31, 2020 |
||||||||
Granted |
||||||||
Exercised |
( |
|||||||
Cancelled |
( |
|||||||
Outstanding – December 31, 2021 |
||||||||
Granted |
||||||||
Exercised |
( |
|||||||
Cancelled |
( |
|||||||
Outstanding – December 31, 2022 |
Number of share options (000`s) |
Number of share options vested (000’s) |
Exercise price per share option C$ |
Expiry date |
|||||||||
December 31, 2022 |
||||
Weighted average exercise price for exercisable options |
C$ |
|||
Weighted average share price for options exercised |
C$ |
|||
Weighted average years to expiry for exercisable share options |
2022 |
2021 |
2020 |
||||||||||
Risk-free interest rate |
||||||||||||
Expected life of options (years) |
||||||||||||
Expected volatility |
||||||||||||
Expected dividend |
e) |
Share purchase warrants |
Share price |
C$ |
|||
Risk-free interest rate |
||||
Expected dividend |
||||
Expected life |
||||
Expected volatility |
Number of share purchase warrants |
Weighted average exercise price C$ |
|||||||
Outstanding – December 31, 2019 |
||||||||
Issued |
||||||||
Outstanding – December 31, 2020 |
||||||||
Exercised |
( |
|||||||
Outstanding – December 31, 2021 |
||||||||
Exercised Expired |
( ( |
|||||||
Outstanding – December 31, 2022 |
Number of share purchase warrants |
Exercise price per share purchase warrant C$ |
Expiry date |
||||||
f) | Deferred share units |
Number of DSUs (000’s) | ||
Outstanding – December 31, 2019 |
- | |
Granted |
||
Outstanding – December 31, 2020 |
||
Granted |
||
Outstanding – December 31, 2021 |
||
Granted |
||
Redeemed |
( | |
Outstanding – December 31, 2022 |
11 |
Segmented information |
2022 |
2021 |
|||||||
Canada |
||||||||
Property and equipment |
$ |
$ | ||||||
Deposits and other |
||||||||
$ |
$ | |||||||
Other |
||||||||
Property and equipment |
$ |
$ | ||||||
Other assets |
||||||||
Deposits and other |
||||||||
$ |
$ |
12 |
Project expenditures |
2022 |
2021 |
2020 | ||||
Mongolia |
$ |
$ |
$ | |||
Other |
||||||
$ |
$ |
$ |
13 |
Income tax |
2022 |
2021 |
2020 | ||||
Loss for the year before income taxes |
$ ( |
$ ( |
$ ( | |||
Statutory rate |
||||||
Expected income tax recovery |
( |
( |
( | |||
Permanent differences and other |
( |
|||||
Difference in foreign tax rates |
||||||
Effect of change in future tax rates |
||||||
Expiry of tax losses |
||||||
Change in deferred tax assets not recognized |
||||||
Total income tax recovery |
$ |
$ |
$ |
2022 |
2021 |
2020 | ||||
Current income tax recovery |
$ |
$ |
$ | |||
Deferred income tax expense |
||||||
Total income taxes |
$ |
$ |
$ |
2022 |
2021 |
2020 | ||||
Deferred income tax assets: |
||||||
Non-capital loss carryforward |
$ |
$ |
$ | |||
Resource expenditures |
||||||
Equipment |
||||||
Share issue and legal costs |
||||||
Other |
||||||
Unrecognized tax assets |
( |
( |
( | |||
Net deferred income tax assets |
||||||
Deferred income tax liabilities: |
||||||
Foreign exchange on loan |
( | |||||
Mineral property interests |
( | |||||
Net deferred income tax liabilities |
$ |
$ |
$ ( | |||
Net deferred income tax |
$ |
$ |
$ |
Net deferred income tax |
$ |
$ |
$ |
14 |
Financial instruments |
a) | Fair value classification of financial instruments |
December 31, 2022 |
FVTPL |
Amortized cost (financial assets) |
Amortized cost (financial liabilities) |
Total |
||||||||||||
Financial assets |
||||||||||||||||
Cash and cash equivalents |
$ |
$ |
$ |
$ |
||||||||||||
Receivables |
||||||||||||||||
Deposits |
||||||||||||||||
Total financial assets |
$ |
$ |
$ |
$ |
||||||||||||
Financial liabilities |
||||||||||||||||
Accounts payable and accrued liabilities |
$ |
$ |
$ |
$ |
||||||||||||
Lease liabilities |
||||||||||||||||
Loan payable |
||||||||||||||||
Total financial liabilities |
$ |
$ |
$ |
$ |
December 31, 2021 |
FVTPL |
Amortized cost (financial assets) |
Amortized cost (financial liabilities) |
Total |
||||||||||||
Financial assets |
||||||||||||||||
Cash and cash equivalents |
$ | $ | $ | $ | ||||||||||||
Receivables |
||||||||||||||||
Deposits |
||||||||||||||||
Total financial assets |
$ | |
$ | $ | $ | |||||||||||
Financial liabilities |
||||||||||||||||
Accounts payable and accrued liabilities |
$ | $ | $ | $ | ||||||||||||
Lease liabilities |
||||||||||||||||
Loan payable |
||||||||||||||||
Total financial liabilities |
$ | |
$ | |
$ | |
$ | |
b) |
Financial risk management |
i) |
Credit risk |
ii) |
Liquidity risk |
iii) |
Interest rate risk |
iv) |
Foreign exchange risk |
December 31, 2022 |
December 31, 2021 |
|||||||
Cash and cash equivalents |
$ |
$ | ||||||
Accounts payable and accrued liabilities |
( |
( |
||||||
$ |
$ |
15 |
Capital management |
16 |
Commitments and contingencies |
Total |
Less than 1 year |
1 - 3 years |
3-5 years |
More than 5 years |
||||||||||||||||
Lease commitments |
$ | $ | |
$ | |
$ | |
$ |
17 |
Related party transactions |
2022 |
2021 |
2020 |
||||||||||
Directors’ fees |
$ |
$ | |
$ | |
|||||||
Salaries and benefits |
$ |
$ | |
$ | |
|||||||
Share-based compensation |
$ |
$ | |
$ | |
18 |
Subsequent events |
• | stock options to purchase ; and |
• |
share purchase warrants to purchase |